Skip to main content

Endovia Health Sciences, Inc.

EDVA
Exchange
NYSE
Industry
Beverages
SEC CIK
0001553788

No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Endovia Health Sciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of EDVA: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders2832+4
Shares2.97M3.80M+834.0K (+28.1%)
Value$1.37M$903.3K−$462.6K (−33.9%)

New holders (9)

Institutions that held Endovia Health Sciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to EDVA in Q2 2024
InstitutionSharesValue% of portfolio
XTX Topco Ltd28,547$6.57K0.00%
Virtu Financial LLC23,535$5.00K0.00%
McCollum Christoferson Group LLC17,000$3.91K0.00%
HRT Financial LP14,934$3.00K0.00%
Jane Street Group, LLC11,587$2.67K0.00%
Delos Wealth Advisors, LLC667$1540.00%
Cypress Capital, LLC300$690.00%
Bank of America Corp230$530.00%
Northwestern Mutual Wealth Management Co3$10.00%

Sold out (5)

Institutions that held Endovia Health Sciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of EDVA in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
HighTower Advisors, LLC550,000$253.0K
Charles Schwab Investment Management Inc20,360$9.37K
Bank of Montreal10,000$5.10K
Warther Private Wealth, LLC10,000$4.60K
Wells Fargo & Company219$101